ClinicalTrials.govpublic full text
Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer
metastatic pancreatic cancer, pancreatic cancer, clivatuzumab tetraxetan, 90y-clivatuzumab tetraxetan, immu-107, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 862101
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.